Long-Term Survival, Illness Severity, and Time-to-Treatment Analysis in Dogs with Immune-Mediated Hemolytic Anemia Following Intravenous Allogeneic Mesenchymal Stem Cell Therapy: A Multicohort Follow-Up Study

Stem Cells and Development · Published 2026-07-17 · DOI 10.1177/15473287261467226

Free full text

Authors (3)

Steven D. Garner, Emily D. Laughrun, Melinda Wharton

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Garner, S., Laughrun, E., Wharton, M. (2026). Long-Term Survival, Illness Severity, and Time-to-Treatment Analysis in Dogs with Immune-Mediated Hemolytic Anemia Following Intravenous Allogeneic Mesenchymal Stem Cell Therapy: A Multicohort Follow-Up Study. Stem Cells and Development. https://doi.org/10.1177/15473287261467226

Related articles